3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Hot Flashes
2
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
1
Interventions
Specimen Handling
9
Tamoxifen
8
Radiotherapy
6
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Letrozole
3
Anastrozole
3
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Patient Navigation
2
Observation
2
Metformin
2
Mastectomy
2
Magnetic Resonance Spectroscopy
2
Genetic Testing
2
Biopsy
2
trastuzumab biosimilar HLX02
1
ruxolitinib
1
poly ICLC
1
palbociclib
1
fezolinetant
1
elacestrant
1
afimoxifene
1
abemaciclib
1
Trastuzumab
1
Testosterone
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
fezolinetant
×
1 year
×
Clear all
NCT06617455
2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2
Terminated
9 enrolled